Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Synthetic Research Peptide Intermediate
Synthetic Research Peptide Intermediate buy - large image1
Synthetic Research Peptide Intermediate buy - image1
Synthetic Research Peptide Intermediate buy - image2
Synthetic Research Peptide Intermediate buy - image3
Synthetic Research Peptide Intermediate buy - image4
Synthetic Research Peptide Intermediate buy - image5
Synthetic Research Peptide Intermediate buy - image6

Synthetic Research Peptide Intermediate

TDS 7482 Inquiries

Unit Price:

$50/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Research Grade

Content:

99%

Port:

SHENZHEN

Brand:

gh

Packaging:

10mg

Sample Available:

Yes

Price valid (until):

2027-09-16

Company Type:
Trader
Location:
China
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
Qualification:
Main Products:

Retatrutide,Tirzepatide,Semaglutide,GHK-CU

  • Product Details

  • Seller Information

  • Inquiry History

  • Description
    Items Specifications
    Product Name Synthetic Research Peptide
    Appearance White to off-white lyophilized powder
    Purity (HPLC) ≥98.0%
    Solubility Soluble in purified water
    Storage Condition Sealed storage at -20℃, protected from light, avoid repeated freeze-thaw cycles
    Application In-vitro Laboratory Research Only
    Supporting Documents COA, HPLC Spectrum
    Packaging Sealed glass vial / Aluminum foil bag

    Important Statement

    This product is synthetic peptide biochemical intermediate, only for in-vitro laboratory scientific research, chemical structure analysis, organic synthesis experiments and chromatographic analysis. It is prohibited to be used for human application, in-vivo animal experiments, clinical testing, medical diagnosis and treatment, and any application on living organisms.

    Product Overview

    This item is solid-phase synthesized peptide raw material, white to off-white lyophilized powder with excellent water solubility. Produced by low-temperature lyophilization and purification technology, it delivers stable batch performance and low impurities. Widely used in basic biochemical research, peptide synthesis process exploration, laboratory reference sample analysis and pre-research of pharmaceutical intermediates.

    We stock various sample sizes and bulk raw materials. Custom specifications, neutral unbranded packaging and private labeling services are available for research institutes, biological laboratories and pharmaceutical R&D enterprises to meet demands from preliminary trial experiments and long-term research projects.

    Product Advantages

    1. Manufactured by mature solid-phase synthesis and purification technology; high-purity lyophilized powder with stable physicochemical indicators between batches;
    2. Multiple specifications in stock. Samples and bulk goods are available to fit research experiments at different stages;
    3. Complete test documents including COA certificate and HPLC chromatogram can be offered for every batch to realize traceable quality control;
    4. Neutral confidential packaging and custom labels are supported to protect clients’ confidential research information;
    5. Standardized order workflow, sufficient inventory. Re-inspection, subpackaging and shipment can be arranged quickly after order confirmation;
    6. Suitable for in-vitro biochemical experiments, organic synthetic route research and chromatographic analysis;
    7. Small trial orders are accepted to lower customers’ initial experimental investment cost.

    Quality Control

    We implement full standardized quality inspection. Purity test and appearance verification will be carried out before shipment. Inspection items cover appearance check, HPLC purity test and packaging tightness test. All subpackaging work is completed under clean environment. Hermetic packaging effectively reduces risk of moisture absorption and oxidation during storage and cross-border transportation to guarantee long-term sample stability. Electronic test documents can be provided for clients’ filing and recheck.

    Packaging Introduction

    Standard sample package: independent sealed glass vial Bulk package: vacuum aluminum foil bag Outer package: thick shock-resistant carton with buffer materials Optional service: neutral unbranded confidential packaging, custom label printing All goods will undergo tightness recheck before delivery to resist extrusion, humidity and light exposure during international logistics.

    Logistics & Lead Time

    Multiple international logistics solutions including global express and cross-border special lines can be selected according to destination country and time requirement. Tracking number will be provided after shipment for real-time logistics monitoring. Lead Time: Goods will be inspected, packed and shipped within 48–72 hours after order confirmation Shipping Time: Normally 7–15 working days, subject to customs clearance efficiency and selected shipping channel.

    Reasons to Choose Us

    1. Strict standardized quality control. Complete test documents are available for each batch with traceable quality;
    2. Professional lyophilized peptide technology, stable purity and good solubility, resistant to degradation during storage and transportation;
    3. Diversified customized solutions including specification adjustment, neutral confidential packaging and private label printing;
    4. Long-term spot inventory and stable supply to avoid stock shortage and delivery delay;
    5. Efficient order processing, rapid arrangement of subpackaging and timely logistics update;
    6. Cross-border protective packaging, moisture-proof, light-proof and anti-extrusion for long-distance international transportation;
    7. Flexible small-order policy supporting laboratory sample purchase for preliminary research;
    8. Professional team offers pre-sales parameter consultation, storage guidance and after-sales technical support for worry-free purchasing.
    9. Shop Synthetic Research Peptide Intermediate-Detailed Image 1 Shop Synthetic Research Peptide Intermediate-Detailed Image 2 Shop Synthetic Research Peptide Intermediate-Detailed Image 3 Shop Synthetic Research Peptide Intermediate-Detailed Image 4 Shop Synthetic Research Peptide Intermediate-Detailed Image 5 Shop Synthetic Research Peptide Intermediate-Detailed Image 6 Shop Synthetic Research Peptide Intermediate-Detailed Image 7 Shop Synthetic Research Peptide Intermediate-Detailed Image 8 Shop Synthetic Research Peptide Intermediate-Detailed Image 9 Shop Synthetic Research Peptide Intermediate-Detailed Image 10

    Payment and Shipping Methods

    • DHL Global Express

      Door-to-door delivery globally, full cold chain with dry ice, trackable tracking number, smooth customs clearance worldwide.
    • FedEx Global Air Express

      Stable air space, professional customs clearance service, suitable for medium & bulk orders.
    • Local National Postal Lines (Including USPS)

      Cost-effective for 1g-10g small trial samples, final delivery by local post office.
    • Bank T/T Wire Transfer: Formal USD settlement, for bulk orders
    • USDT: USD-pegged stable coin, no exchange loss, widely used in chemical trade
    • Bitcoin BTC: Peer-to-peer on-chain private settlement
    • Shop PT41 Research Grade Synthetic Peptide-Detailed Image 16 Shop PT41 Research Grade Synthetic Peptide-Detailed Image 17 Shop PT41 Research Grade Synthetic Peptide-Detailed Image 18 Shop PT41 Research Grade Synthetic Peptide-Detailed Image 19
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,Semaglutide,GHK-CU

    Location:

    Plot 1, No. 205 Tongbao Road, Jiangdong Subdistrict, Yiwu City, Jinhua City, Zhejiang Province

    Payment Terms:

    TT against B/L draft before shipment,100% TT in advance

    Year of Establishment:

    2026

  • Inquiry History
    7482 Inquiries
    Country Product Purchase Quantity Date Posted
    Lithuania

    Retatrutide

    30 MG Oct 27, 2026
    United States

    Retatrutide

    10 MG Oct 27, 2026
    Greece

    Retatrutide

    30 MG Oct 27, 2026
    Germany

    Retatrutide

    20 MG Oct 27, 2026
    Canada

    Retatrutide

    30 MG Oct 27, 2026
    United States

    retatrutide

    40 MG Oct 27, 2026
    Spain

    Retatrutide

    30 MG Oct 27, 2026
    United Kingdom

    Retatrutide

    20 MG Oct 27, 2026
    United States

    Retatrutide

    40 MG Oct 27, 2026
    United States

    Retatrutide

    50 MG Oct 27, 2026
    United States

    retatrutide

    30 MG Oct 27, 2026
    United States

    retatrutide

    200 MG Oct 27, 2026
    Spain

    retatrutide

    200 MG Oct 27, 2026
    United States

    Retatrutide

    100 PCS Oct 27, 2026
    New Zealand

    Retatrutide

    20 PCS Oct 27, 2026
    Netherlands

    Retatrutide

    100 20' Fcl Oct 27, 2026
    United States

    Retatrutide

    300 MG Oct 27, 2026
    Canada

    Retatrutide

    1 G Oct 26, 2026
    Switzerland

    Retatrutide

    1 KG Oct 26, 2026
    United States

    Retatrutide

    10 MG Oct 26, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.